TRANSPLANTATION IS AN ESTABLISHED therapy for end-stage organ failure. Although immunosuppressive therapy has greatly elevated the chance of success in short-term grafts, it is often accompanied by severe side effects (6) . Dendritic cells (DCs) are the most potent antigen-presenting cells and play a critical role in the initiation of primary immune responses. The functional activity of DCs depends mainly on their state of activation and differentiation. Mature DCs (mDCs) induce development of T effector cells, whereas immature DCs (imDCs) maintain peripheral tolerance (11) . mDCs express elevated levels of MHC and costimulatory molecules, whereas imDCs are deficient in costimulatory molecules. Therefore, imDCs present antigen to T cells in the absence of costimulation, which leads to T cell anergy or the generation of regulatory T cells (Tregs) (5) . Tolerogenic dendritic cells (tDCs) are generally characterized by an immature or semimature phenotype, with reduced expression of costimulatory molecules. tDCs are therefore a promising tool for specific cellular therapy to induce immunological tolerance in transplantation and autoimmunity (1) .
Interleukin (IL)-10 is an immunomodulatory cytokine that modulates the immune response. The main role of IL-10 is to inhibit antigen-specific T cells from undergoing proliferation and to keep DCs from secreting inflammatory cytokines. Some studies have indicated that IL-10-producing DCs exhibit powerful tolerogenic characteristics with elevated IL-10 production and low T cell activation, as well as the potential to induce Tregs. Moreover, in a functional suppression assay only IL-10 DC induced Tregs, which strongly suppressed T cell reactivity (1, 2, 10) . Other experiments have shown that IL-10 inhibits expression of costimulatory molecules in phagocytes. It also inhibits mononuclear phagocytes from presenting antigens and reduces T cell-and B cell-mediated immune responses. In addition to its effect on T cells, IL-10 inhibits the immune activity of other cell types, such as NK cells, mononuclear cells, and macrophages (17) . Taken together these findings suggest that IL-10 acts as a potential negative regulator of cellular proliferation during the immune response and inflammation, which plays an important role in immune tolerance. Therefore, IL-10 has emerged as a promising therapeutic factor for the treatment of autoimmune reactions during transplantation.
In general, transforming growth factor (TGF)-␤1 plays a crucial role in immune tolerance. Studies have shown that TGF-␤1 has multiple inhibitory effects on the proliferation, differentiation, and survival of T cells, B cells, macrophages, and other immune cells (16, 22) . It is also an essential cytokine for the differentiation of Th1 cells and inhibits proliferation of allogeneic lymphocytes in vitro. TGF-␤1-DCs also decrease IL-12 expression, which plays an important role in Th1 differentiation (20) . They inhibit Thl secretion of tumor necrosis factor (TNF)-␣, IL-2, and interferon-␥, and prevent Th2 cells from secreting IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13. TGF-␤1-DCs induce CD41Foxp31 Tregs, and TGF-␤1-imDCs inhibit imDCs function (3). They are known to exert immuno-suppressive effects upon various target cells in the immune system in vitro and have been shown to mediate immunosuppressive effects in vivo (26) . Taken together, these findings indicate TGF-␤1 plays a major role in maintaining immunological self-tolerance.
Both IL-10 and TGF-␤1 are critical immune modulatory genes, and their modulation alters DC function. Previously, imDC transfected with recombinant plasmid containing both IL-10 and TGF-␤1 resulted in the downregulation of MHC class II, CD80, and CD86 (4). IL-10-TGF-␤1-imDC induced T cell hyporesponsiveness, limiting proliferation. However, IL-10-TGF-␤1-imDCs were more effective than IL-10-imDC and TGF-␤1-imDC. DC coexpressing IL-10 and TGF-␤1 enhanced the tolerogenicity of imDC. However, thus far, we are unaware of quantitative studies investigating the suppressive function of imDC cotransfected with IL-10 and TGF-␤1 in donor-specific tolerance following organ transplantation. The aim of this study was to use a rat liver transplantation model to examine the immune tolerance effects of IL-10-TGF-␤1-imDC, and to compare the effect of IL-10-TGF-␤1-imDC with IL-10-imDC and TGF-␤1-imDC. Interestingly, IL-10-imDC and TGF-␤1-imDC were found to inhibit imDC immunity and enhanced their tolerogenicity. Injection of donor imDC cotransfected with IL-10 and TGF-␤1 prolonged liver allograft survival. Our study describes a potentially promising way to enhance donorspecific tolerance during organ transplantation.
MATERIALS AND METHODS

Animals.
Male dark agouti (DA) and Lewis rats (8 -10 wk old and weighing 230 Ϯ 20 g) were purchased from the laboratory animal center of the second affiliated hospital at Harbin Medical University (Heilongjiang, China) and Shanghai SLAC Laboratory Animal (Shanghai, China). A total of 161 pairs of DA/Lewis rats were divided into the following seven groups: control group (n ϭ 23), mDC group (n ϭ 23), imDC group (n ϭ 23), vector-imDC group (n ϭ 23), IL-10-imDC group (n ϭ 23), TGF-␤1-imDC group (n ϭ 23), and IL-10-TGF-␤1-imDC group (n ϭ 23). Five rats in each group were killed at days 3, 7, and 10 posttransplantation for harvest of liver specimens. Eight rats posttransplantation in each group were used for survival observation. Two rats in the control group, imDC group, and TGF-␤1-imDC group and one rat in the other groups died after surgical operation within 30 min. Experimental conditions were kept the same in all groups. All rats were housed in microisolator cages in the barrier facility of Fujian Medical University (Fuzhou, China). All experiments were performed according to the guidelines of and were approved by the Institutional Animal Care and Use Committee of Fujian Medical University.
Preparation of DCs. Rat bone marrow cells (RBMCs) were collected from the tibia and femur of DA rats by flushing with a 25-gauge needle. RBMCs were cultured in RPMI 1640 medium supplemented with 15% vol/vol fetal bovine serum medium (Life Technologies, San Diego, CA) and 10 ng/ml recombinant rat granulocyte-macrophage colony-stimulating factor (rat recombinant GM-CSF; PeproTech, Rocky Hill, NJ) at 37°C plus 5% CO 2 for 8 days. Cells were plated in six-well plates at a density of 1-2 ϫ 10 6 /ml cells in RPMI 1640 medium supplemented with 15% heat-inactivated fetal calf serum, 10.0 ng/ml rat rIL-4 (PeproTech), and 20.0 ng/ml of rat recombinant GM-CSF. Old medium with floating cells was gently removed after 3 days and replaced with fresh medium. After 2-3 days, nonadherent cells and loosely adherent aggregated proliferating DC were harvested. mDCs were prepared in a similar manner except for the use of 10 ng/ml rat recombinant GM-CSF and 10 ng/ml rat recombinant TNF-␣ (PeproTech) at day 6 as opposed to day 8.
Identification of imDC and mDC. imDCs and mDCs were confirmed morphologically using an inverted microscope (Nikon, Melville, NY) and scanning electron and transmission electron microscopy (Zeiss, Berlin, Germany). Both types of DCs were stained with anti-OX62-FITC, anti-CD80-FITC, and anti-CD86-FITC. Mouse IgG was used as a negative control. Cells were then incubated with appropriate secondary antibodies for 30 min at 4°C, after which the cells were washed two times in PBS with 1% wt/vol BSA. FACS analysis was performed using FACScan flow cytometry (BectonDickinson Immunocytometry Systems, San Jose, CA).
Plasmids. Plasmids encoding pIRES2-EGFP-hIL-10 and pIRES2-EGFP-hTGF-␤1 were kindly provided by Dr. G. Huang (Fujian Medical University). Plasmid inserts were confirmed by double digestion with restriction enzymes XhoI ϩ EcoRI and BglII ϩ HindIII, respectively. IL-10 and TGF-␤1 genes were also PCR amplified and confirmed by sequencing. The following primers were used: IL-10 forward (F): 5=-CCGCTCGAG CCACC ATGCACAGCTCAGCACT-GCTCT-3=; IL-10 reverse (R): 5=-CCGGAATTC TCAGTTTCG-TATCTTCATTGTC-3=; TGF-␤1F: 5=-GCCCTGGA CACCAACTAT-TGCT-3=; TGFϪ␤1R: 5=-TCAGCTGCACTTGCAGGAGCGC-3=. Fig. 1 . A: serum alanine transaminase (ALT) levels on days 3, 7, and 10 postliver transplantation time points. ALT levels increased significantly 7 and 10 days after transplantation in the control and mature dendritic cell (mDC) groups compared with those measured on the 3rd day (P Ͻ 0.001). ALT levels in interleukin (IL)-10 and transforming growth factor (TGF)-␤1 immature dendritic cell (imDC) groups were significantly lower than those of the imDC, vector imDC, IL-10 imDC, and TGF-␤1 imDC groups (P Ͻ 0.05). B: serum total bilirubin (TBIL) levels on days 3, 7, and 10 postliver transplantation time points. TBIL levels significantly increased 7 and 10 days after transplantation in the control and mDC groups compared with those measured on the 3rd day (P Ͻ 0.001). TBIL levels in the IL-10 and TGF-␤1 imDC groups were significantly lower than those of the imDC, vector imDC, IL-10 imDC, and TGF-␤1 imDC groups (P Ͻ 0.05).
Transfection and identification. DCs were transfected on day 7 with pIRES2-EGFP-hIL-10, pIRES2-EGFP-hTGF-␤1, or empty control vector using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. The resulting DCs were termed IL-10-TGF-␤1-imDC, IL-10-imDC, TGF-␤1-imDC, and vector-imDC. imDC protein was detected by ELISA (Jingmei Biotech, Shenzhen, China) and Western blot analysis.
Establishment of a rat heterotopic liver transplantation model. A heterotopic liver transplantation model was established using DA rats as donors and Lewis rats as recipients, as described previously (14, 15, 19) . Syngeneic transplants were used as controls. In treatment groups, 1 ml normal saline containing 2 ϫ 10 6 DA-derived imDC, mDC, vector-imDC, IL-10-imDC, TGF-␤1-imDC, and IL-10-TGF-␤1-imDC DCs were injected intravenously into Lewis rats 5 days before liver transplantation. Examination of recipients was used to determine allograft survival, and rejection was confirmed histologically. To test the capacity of IL-10-and TGF-␤1-modified imDC for prolonging liver allograft survival, DA donor-derived TGF-␤1-modified imDC (2 ϫ 10 6 cells in 100 l PBS) was infused intravenously into Lewis recipients on day 7.
Liver function measurement. Total bilirubin (TBIL) and alanine transaminase (ALT) serum levels were quantitated to assess liver function on days 3, 7, and 10 following liver transplantation.
Cytokine measurement by ELISA. IL-12 serum concentration was determined by ELISA (450 nm) using Quantikine M kits (Jingmei Biotech), following the manufacturer's instructions.
Terminal transferase-mediated UTP nick end-labeling method.
Animals were killed on days 3 and 7 following liver transplantation, and tissue was harvested. Grafted liver was isolated, fixed in formalin, and embedded in paraffin. Four-micrometer sections were then cut, deparaffinized, and digested for 15 min by protease K. T cell apoptosis was detected by terminal transferase-mediated UTP nick endlabeling (TUNEL) using an in situ apoptosis detection kit (Boehringer, Mannheim, Germany). Paraffin sections were deparaffinized in xylene, rehydrated, and incubated with 20 mg/ml of proteinase K for 10 min and rinsed in distilled water. Endogenous peroxidase activity was inhibited with 3% hydrogen peroxide. Sections were then incubated with equilibration buffer for at 10°C for 15 s, followed by TdT enzyme in a humidified atmosphere at 37°C for 60 min. Sections were subsequently prewarmed in working strength stop wash buffer at room temperature for 10 min, followed by antistreptavidin-peroxidase for 45 min. PBS washes were used after each step. DAB staining and counter staining was performed in hematoxylin and eosin. Two individuals examined slides independently. Approximately 100 TUNEL-positive cells were counted in randomly chosen fields per each case, and the percentage of apoptotic cells stained brown was determined.
Histological analysis. Histological assessments play an important role in the diagnosis and management of liver allograft rejection. The allografts were examined on days 3, 7, and 10 following transplantation. The overall rejection grade was assessed, and the rejection activity index (RAI) was calculated according to the Banff schema. For statistical analysis, the RAI score was subsequently grouped as follows: RAI below 2 was classified as absent, 2 as indeterminate rejection, 3-4 as mild, 5-6 as moderate, and greater than 6 as severe (13) . All histological evaluations were done in a double-blinded manner by two experimenters. Statistical analysis. SPSS version 12 (IBM, Chicago, IL) Analytical Software was used for analysis, and the values are shown as means Ϯ SD. Differences between groups were analyzed using ANOVA or Student's t-test. Graft survival data were analyzed statistically by life table methods, and differences in survival time were tested with the log-rank method. A P value of 0.05 was considered statistically significant.
RESULTS
Liver function evaluation.
The normal ALT and TBIL levels were 26.3 Ϯ 7.3 U/l and 11.36 Ϯ 4.35 mol/l, respectively, in the Lewis rats. After 7 and 10 days of transplantation, the ALT and TBIL levels were significantly increased in the control and mDC groups (P Ͻ 0.001) but were significantly decreased in the imDC, vector imDC, IL-10 imDC, and TGF-␤1 imDC groups compared with values obtained on the 3rd day (P Ͻ 0.05). Meanwhile, the ALT and TBIL levels were markedly decreased after 7 and 10 days of transplantation in the imDC, vector imDC, IL-10 imDC, and TGF-␤1 imDC groups when compared with those of the control and mDC groups. ALT and TBIL levels in the IL-10 and TGF-␤1 imDC groups were significantly lower than those in the imDC, vector imDC, IL-10 imDC, and TGF-␤1 imDC groups (P Ͻ 0.05) (Fig. 1, A and B) . These results indicate that liver function in the IL-10-and TGF-␤1 imDC-treated groups was continuously being restored after transplantation. Our data suggest that the functional reserve of the liver is maintained in the presence of elevated levels of IL-10 and TGF-␤1.
Detection of apoptosis by TUNEL. TUNEL-positive lymphocytes were detected in the portal area in liver sections of every group (Fig. 2, A-F) . The percentage of TUNEL-positive cells was significantly higher in the IL-10 and/or TGF-␤1-imDCs groups than that of controls (P Ͻ 0.05), particularly in those treated with IL-10-TGF-␤1-imDC (Fig. 2G) . In summary, the percentage of TUNEL-positive cells increased in the presence of elevated IL-10 and TGF-␤1. The stimulation was highest in the IL-10-TGF-␤1-imDC group. Values are means Ϯ SD. DC, dendritic cells; mDC, mature dendritic cells; imDC, immature dendritic cells; TGF-␤1, transforming growth factor-␤1; IL, interleukin. Unpaired 2-tailed Student's t-test. The IL-10-TGF-␤1-imDC recipients exhibited lower serum IL-12 than that of controls and those receiving mDCs, imDCs, and vector-imDCs (*P Ͻ 0.05). imDC-, vector-imDC-, TGF-␤1-imDC-, IL-10-imDC-, and TGF-␤1-IL-10-imDC-treated animals exhibited lower IL-12 levels than those of controls and mDC groups at day 3 posttransplantation ( ⌬ P Ͻ 0.05). In addition, TGF-␤1-imDCs, IL-10-imDCs, and TGF-␤1-IL-10-imDCs were all lower relative to those of control, mDCs, imDCs, and vector-imDCs groups at day 7 posttransplantation (**P Ͻ 0.05). Finally, imDCs, vector-imDCs, TGF-␤1-imDCs, IL-10-imDCs, and TGF-␤1-IL-10-imDCs all exhibited lower IL-12 levels than those of control and mDC-treated rats at day 7 posttransplantation ( ⌬⌬ P Ͻ 0.05). 
A C B D E F
IL-10 and TGF-␤1 overexpression downregulates IL-12 following liver transplantation.
IL-12 serum levels in rats that had received treatment with IL-10 and/or TGF-␤1-imDC treatment compared with the mDC, imDC, and vector-imDC control groups on days 3 and 7 are shown in Table 1 . The IL-10-TGF-␤1-imDC recipients exhibited lower serum IL-12 than that of controls and those receiving mDCs, imDCs, and vector-imDCs (P Ͻ 0.05). Animals treated with imDCs, vector-imDCs, TGF-␤1-imDCs, and IL-10-imDCs, and TGF-␤1-IL-10-imDC-treated animals exhibited lower IL-12 levels than those of controls and mDC groups at day 3 posttransplantation (P Ͻ 0.05). In addition, TGF-␤1-imDCs, IL-10-imDCs, and TGF-␤1-IL-10-imDCs were all lower relative to the control, mDCs, imDCs, and vector-imDCs groups at day 7 posttransplantation (P Ͻ 0.05). Finally, imDCs, vector-imDCs, TGF-␤1-imDCs, IL-10-imDCs, and TGF-␤1-IL-10-imDCs all exhibited lower IL-12 levels than control and mDC-treated rats at day 7 posttransplantation (P Ͻ 0.05). These results indicate IL-10 and/or TGF-␤1 overexpression downregulates IL-12 levels following liver transplantation.
Histological assessment of donor liver grafts. Control RAI values progressively increased for indeterminate, mild, moderate, and severe acute rejection (Fig. 3, A-F, and Table 2 ). After 3, 7, and 10 days of transplantation, RAI values in the imDC, vector imDC, IL-10 imDC, and TGF-␤1 imDC groups were significantly lower compared with those of the control and mDC groups (P Ͻ 0.001). Meanwhile, RAI values in the IL-10 and/or TGF-␤1 imDC groups were significantly lower than those of the imDC and vector imDC groups (P Ͻ 0.01), except for that in the IL-10 imDC group 3 days after transplantation. Moreover, RAI values in the IL-10 and TGF-␤1 imDC group were significantly lower than those in the IL-10 imDC or TGF-␤1 imDC groups (P Ͻ 0.001), except for that in the TGF-␤ 1 imDC group 7 days after transplantation. The higher the total RAI scores, the more likely it was that the graft would fail due to rejection. Our data indicated that the RAI values in IL-10 and/or TGF-␤1-imDC showed mild acute rejection, especially in IL-10 and TGF-␤1-imDC, where the total RAI value was Ͻ4.
Prolonged survival of liver allografts in recipients infused with IL-10 and TGF-␤1-imDC. The survival of liver grafts following infusion of IL-10 and/or TGF-␤1-imDC was Ͼ40, 58, or 90 days (Fig. 4) . Thus, survival time was prolonged, especially in IL-10-TGF-␤1-imDC. The survival time in rats treated with IL-10 and/or TGF-␤1-imDCs was significantly prolonged compared with that in the mDC, imDCs, vectorimDC, and control groups (all P Ͻ 0.001). However, no significant differences were observed between the imDC and vector-imDC groups (P Ͼ 0.05). Additionally, no significant differences were detected when comparing the control group with the mDC group (P Ͼ 0.05). These results indicate that infusion of IL-10 and/or TGF-␤1-imDC induces alloantigen tolerance and prolongs liver allograft survival. IL-10-TGF-␤1-imDC was more effective than IL-10-imDC or TGF-␤1-imDC individually.
DISCUSSION
In the present study, we investigated the effects of imDC cotransfected with IL-10 and TGF-␤1 genes (IL-10-TGF-␤1-imDC) in inducing immune tolerance following liver transplantation in rats. Infusion of IL-10 and/or TGF-␤1-imDC, particularly IL-10-TGF-␤1-imDC, prolonged liver graft survival. Liver grafts survived Ͼ40, 58, or 90 days, depending on the treatment, indicating that IL-10 or/and TGF-␤1-imDC induces alloantigen tolerance and prolongs liver allograft survival. IL-10-TGF-␤1-imDC was more effective than IL-10-imDC and TGF-␤1-imDC. These results suggest injection of donor imDC cotransfected with IL-10 and TGF-␤ 1 genes prolongs survival of liver allografts.
We have previously examined the function of imDC cotransfected with IL-10 and TGF-␤1 genes in vitro (4) and found that IL-10-TGF-␤1-imDC downregulates MHC class II, CD80, and CD86 in imDCs. IL-10-TGF-␤1-imDC induces T cell hyporesponsiveness and inhibits proliferation. Interestingly, IL-10-TGF-␤1-imDC was more effective than either IL-10-imDC or TGF-␤1-imDC. IL-10 and TGF-␤1 genes coexpressed in DC affected the immunity of imDCs and enhanced their tolerogenicity.
We overexpressed two cytokines, IL-10 and TGF-␤1, in bone marrow-derived imDCs and investigated their immunity and tolerogenicity in vitro. By using DA rats as donors and Lewis rats as recipients, a heterotopic liver transplantation model was established. In treated groups, DA-derived imDC, mDC, vector-imDC, IL-10-imDC, TGF-␤1-imDC, or IL-10-TGF-␤1-imDC DCs were injected intravenously into Lewis rats 5 days before the liver transplantation. We observed imDCs cotransfected with IL-10 and TGF-␤1 genes inhibit DC differentiation and maturation. Histological assessment of donor liver grafts revealed RAI values in IL-10-and/or TGF-␤1-imDC-treated rats consistent with mild acute rejection. For example, in IL-10 and TGF-␤1-imDCs, the total RAI value was Ͻ4. However, the RAI values in controls increased progressively for moderate and severe acute rejection. In our liver allograft model, graft survival in recipients infused with IL-10 and/or TGF-␤1-imDC was prolonged, especially in the IL-10-TGF-␤1-imDC group. Liver grafts survived Ͼ40, 58, and 90 days, with IL-10-TGF-␤1-imDC more effective than IL-10-imDC or TGF-␤1-imDC alone. These results strongly suggest that infusion of IL-10-imDC-and TGF-␤1-modified imDC into recipients induces alloantigen-specific T cell hyporesponsiveness and prolongs liver allograft survival. ELISA data indicated lower levels of serum IL-12 in rats that had received IL-10 and/or TGF-␤1-imDCs compared with those of controls. This suggests that IL-10 and/or TGF-␤1 inhibit IL-12 expression in DCs and Th1 differentiation (9, 21) and that they influence DC function in an autocrine manner. Alternatively, they may affect T cells in a paracrine way and suppress antigen-induced T cell proliferation. IL-10 and TGF-␤1 are important multifunctional regulatory molecules in the immune response. Additional studies show that they are secreted proteins that regulate cellular proliferation, differentiation, and cell death in several immune cells (3, 18) . In our study, the percentage of TUNEL-positive cells was significantly increased in the IL-10 and/or TGF-␤1-imDCs compared with that of controls (P Ͻ 0.05), particularly in IL-10-TGF-␤1-imDC. The percentage of TUNEL-positive cells was significantly increased in the presence of elevated levels of IL-10 and TGF-␤1.
Treatment of monocyte-derived DC with vitamin D 3 (24), TGF-␤1 (8, 16, 23) , rapamycin (21) , dexamethasone (7, 12) , or IL-10 (1, 9) induces inhibitory DC. However, the suppressive capacity of imDC cotransfected with IL-10 and TGF-␤1 has been examined in just a few studies. IL-10 and TGF-␤1 are important multifunctional immune regulatory molecules. TGF-␤1 is a key factor during Th differentiation, which upregulates Foxp3 expression in Th0 cells, driving them to differentiate into CD4 ϩ Foxp3 ϩ Tregs (25). Cai et al. reported (3) that imDCs transfected by TGF-␤1 induce higher percentages of CD4 ϩ Foxp3 ϩ Tregs in vitro. Tregs play a crucial role in immune tolerance, which inhibits the proliferation of autoreactive T lymphocytes (25) .
In summary, we found that IL-10-TGF-␤1-imDC induce allergen-specific T cell immune tolerance more effectively than IL-10-imDC and TGF-␤1-imDC. This suggests that infusion of IL-10-imDC-and TGF-␤1-modified imDCs into recipients induces alloantigen-specific T cell hyporesponsiveness and inhibits antigen-specific immunological responses to liver allografts. It also prolongs survival of liver allografts. Our study provides a potentially promising and alternative approach to enhance donor-specific tolerance during organ transplantation. 
